To date, a single prostate cancer association study has investigated genetic variants within IL-2 for prostate cancer risk and revealed a significant contribution of a synonymous IL-2 exon 1 variant (rs2069763) to disease susceptibility [12]. The gene discussed is IL2; the disease is Familial prostate cancer.